AU7669496A - Method for the intranasal administration of l-dopa prodrugs - Google Patents
Method for the intranasal administration of l-dopa prodrugsInfo
- Publication number
- AU7669496A AU7669496A AU76694/96A AU7669496A AU7669496A AU 7669496 A AU7669496 A AU 7669496A AU 76694/96 A AU76694/96 A AU 76694/96A AU 7669496 A AU7669496 A AU 7669496A AU 7669496 A AU7669496 A AU 7669496A
- Authority
- AU
- Australia
- Prior art keywords
- intranasal administration
- dopa prodrugs
- dopa
- prodrugs
- intranasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55277795A | 1995-11-03 | 1995-11-03 | |
| US552777 | 1995-11-03 | ||
| PCT/US1996/017740 WO1997016181A1 (en) | 1995-11-03 | 1996-11-04 | Method for the intranasal administration of l-dopa prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7669496A true AU7669496A (en) | 1997-05-22 |
Family
ID=24206768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU76694/96A Abandoned AU7669496A (en) | 1995-11-03 | 1996-11-04 | Method for the intranasal administration of l-dopa prodrugs |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7669496A (en) |
| WO (1) | WO1997016181A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS4516A (en) | 1997-07-01 | 1999-01-02 | Gizurarson Sveinbjörn | New pharmaceutical form |
| US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| ES2594867T3 (en) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| BRPI0910575A2 (en) | 2008-04-18 | 2017-06-06 | Arizona Board Of Regents A Body Corp Of The State Of Arizona Acting For And Behalf Of The Univ Of Ar | methods for treating age-related macular degeneration, to limit development of age-related macular degeneration, and to identify compounds for treating age-related macular degeneration, and, composition |
| KR20180073597A (en) | 2015-11-06 | 2018-07-02 | 젬파이어 세러퓨틱스 인코포레이티드 | Treatment of mixed dyslipidemia |
| CA3224977A1 (en) * | 2018-09-28 | 2020-04-02 | Griffith University | Agents and methods for modulating pathogen activity using ligands of complement receptor 3 |
| US11969401B2 (en) | 2019-01-31 | 2024-04-30 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating or limiting development of age-related macular degeneration |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663349A (en) * | 1985-12-30 | 1987-05-05 | Merck & Co., Inc. | Rectally absorbable form of L-dopa |
| US5354885A (en) * | 1992-12-24 | 1994-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Process for preparing ethyl ester of L-DOPA |
-
1996
- 1996-11-04 WO PCT/US1996/017740 patent/WO1997016181A1/en active Application Filing
- 1996-11-04 AU AU76694/96A patent/AU7669496A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997016181A1 (en) | 1997-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPN453895A0 (en) | Spray method | |
| AU7445396A (en) | Two-piece dental abutment | |
| AU5910796A (en) | Method of producing L-lysine | |
| AU4698396A (en) | Process for modifying surfaces | |
| AUPN449295A0 (en) | Radioprotectors | |
| AU1201797A (en) | Nebulizer | |
| AU5779196A (en) | Novel 2-amino-3-phenylpropionic acid derivatives | |
| AU5821096A (en) | New catechol derivatives | |
| AU4838996A (en) | Process for tetraazacycloalkane preparation | |
| HUP9601524A2 (en) | Prodrugs of paclytaxel-derivatives | |
| EP0747346A3 (en) | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | |
| AU6707396A (en) | Processes for the production of amidase | |
| AU7669496A (en) | Method for the intranasal administration of l-dopa prodrugs | |
| AU4352996A (en) | Connector | |
| AU4726196A (en) | Clavulanic acid salts | |
| AU4717896A (en) | Connector | |
| AU2008895A (en) | Connector | |
| AU4396396A (en) | Baby-bathing aid | |
| AU5486396A (en) | Process for the preparation of spiroindolines | |
| AU7096496A (en) | Process for the preparation of 4-methylenepiperidines | |
| AU4926496A (en) | Method for the production of d-chiroinositol | |
| AU4547896A (en) | 4-oxo-2-butenoic acid derivatives | |
| AU7639996A (en) | Nozzle | |
| AU1118797A (en) | Process | |
| AU7335496A (en) | Hyroxamic acid derivatives |